These Specialty Drug Companies Are Primed to Gun Higher
President Trump’s tax cuts are having a ripple effect across the markets as multinational companies like Apple pass the savings on to shareholders via increased dividends or stock buybacks. The same will be true for Big Pharma.
But instead of buying back shares or raising dividends, the drug industry will go a different route—and it will be profitable for investors in this niche sector…
Nick Rokke, CFA
Analyst, The Palm Beach Daily
P.S. Before I start my trading day, I always check my inbox at 7:30 a.m. ET for Jeff Clark’s Market Minute.
Each day, Jeff has new market insights that improve my trading performance… like which charts to watch during the week ahead… which technical indicators to use… or just some tried-and-true strategies from his 30-plus years as an option trader.
I asked Jeff if I could share his newsletter with my Daily readers. And he set up a link you can use to subscribe to the Market Minute with just one click. It’s completely free and should give you the same trading edge I get from reading Market Minute every day. Click here to get started.